Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.54 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.54 |
| ▸ | PGR | P06401 | 1/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.54 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.51 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | OXER1 | Q8TDS5 | 3/20 | 0.46 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.46 |
| ▸ | RXRA | P19793 | 2/20 | 0.46 |
| ▸ | PPARG | P37231 | 2/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.43 |
| ▸ | F7 | P08709 | 2/20 | 0.43 |
| ▸ | F3 | P13726 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28551844 | 0.95 | ADORA3 (0.46) | ADORA3NR1I2PGRPTGS2PDE4D | |
| SCHEMBL28586062 | 0.95 | ADORA3 (0.46) | ADORA3NR1I2PGRPTGS2PDE4D | |
| SCHEMBL13491219 | 0.89 | ALDH1A1 (0.59) | ADORA3NR1I2PGRPTGS2PDE4D | |
| SCHEMBL13491246 | 0.87 | ALDH1A1 (0.61) | ADORA3NR1I2PGRPTGS2PDE4D | |
| SCHEMBL13491210 | 0.87 | ALDH1A1 (0.61) | ADORA3NR1I2PGRPTGS2PDE4D | |
| SCHEMBL11861139 | 0.85 | CNR1 (0.58) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL11861146 | 0.85 | CNR1 (0.58) | ALDH1A1CYP3A4ALOX15HSD17B10TDP1 | |
| SCHEMBL13491254 | 0.85 | ADORA3 (0.53) | ADORA3NR1I2PGRPTGS2PDE4D | |
| SCHEMBL3216687 | 0.82 | ADORA3 (0.49) | ADORA3NR1I2PGRPTGS2PDE4D | |
| SCHEMBL441964 | 0.82 | ADORA3 (0.49) | ADORA3NR1I2PGRPTGS2PDE4D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2010508262-A | — | — | 2010-03-18 | — | — | JP | claimed |
| EP-2102139-A2 | OMEGA-3 LIPID COMPOUNDS | Pronova Biopharma Norge AS (NO) | 2009-09-23 | — | — | EP | claimed |
| WO-2008142482-A2 | OMEGA-3 LIPID COMPOUNDS | PRONOVA BIOPHARMA NORGE AS (US) | 2008-11-27 | — | — | WO | claimed |
| US-20110166228-A1 | COMPOSITION | PRONOVA BIOPHARMA NORGE AS (NO) | 2011-07-07 | — | — | US | disclosed |
| EP-2102139-A2 | OMEGA-3 LIPID COMPOUNDS | Pronova Biopharma Norge AS (NO) | 2009-09-23 | — | — | EP | disclosed |
| WO-2008142482-A2 | OMEGA-3 LIPID COMPOUNDS | PRONOVA BIOPHARMA NORGE AS (US) | 2008-11-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166228-A1 | COMPOSITION | ELOVL3, FFAR3, ALOX5 | ADORA3 209/4885NR1I2 597/4885PGR 2827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.